The Etiometry Platform Now Offers Hospitals Customizable Clinical Pathway Automation to Drive Protocols, Workflows, Guidelines and Help with Staff Efficiency
Interview conducted by:
Lynn Fosse, Senior Editor
Published – April 3, 2023
CEOCFO: Mr. Cooke, when we last talked you were looking at 2022 to expand your reach and become the leader in clinical decisions and support solutions throughout the continuum of care. What have you accomplished at Etiometry over the past year in getting closer or maybe achieving that goal?
Mr. Cooke: Yes, 2022 was a fantastic year for the company. To put it in context, in the past few years, we doubled the number of hospitals we are in and tripled the number of licensed beds that are using our software platform across a broader range of care settings, and increased the number of units we are actively installed in by a factor of four. Last year, we broke into several new types of units -
We discovered new and innovative ways hospitals are using our platform and increased utilization with this knowledge. But the most exciting part about 2022 was being able to see the input from customers come to life in terms of further advancing the Etiometry platform to meet their needs.
One recent innovation that is truly unique and attracting a lot of attention addresses several pain points in healthcare: staffing shortages, the experience-
All of this pushes forward our vision to be the market leader in clinical intelligence software to inform proactive care. We are focused on automating burdensome elements of care to help the clinicians with whom we partner return to their patients instead of being focused on annotating in front of a computer screen. That is our vision and 2022 was the year that we brought a lot of that together.
CEOCFO: Would you give us a concrete example of how this comes into play?
Mr. Cooke: Our platform’s clinical pathway automation capability continuously screens data from connected solutions to identify patients eligible for a clinical guideline or protocol. While the patient is managed under a pathway, the Etiometry platform tracks the patient’s progress and provides a visualization to the care team to facilitate efficient care coordination. We also have clinical pathway reporting that isn’t available in any other mechanism today that helps our clinician partners improve their practice and enhance how they treat these patients. It is also leading to some outcomes improvements with length of stay reduction and others.
As an example, several of our customers have automated their extubation readiness trial with our software. Hospitals usually do an extubation readiness trial or spontaneous breathing trial to assess if a patient can come off a ventilator and is an integral part of ICU liberation – minimizing the harmful effects of invasive ICU interventions. The intent is to identify the appropriate time to remove a patient from a ventilator by comparing the patient’s vital signs and biomarkers to a defined threshold to shorten the time on the ventilator and minimize failed extubations -
We also launched some automated clinical pathways for adult patients coming out of cardiac surgery to inform various workflows, including acute kidney injury, goal-
CEOCFO: Is it that you had not thought of this before, or hospitals suggested it, or the body of knowledge you have changed so that you were able to add this in?
Mr. Cooke: It was actually a major development effort for the company that happened over a few years. We first started automating hospitals’ clinical pathways in early 2021. Then partnered with additional hospitals and expanded to support different clinical pathways. Our goal was to help the hospital indemnify where we could eliminate bottlenecks to ensure patients got timely interventions or eliminate support when appropriate.
The Etiometry platform is distinct in the fact it includes data aggregation and visualization, risk indices and now these automated workflows. It’s a very holistic solution for a hospital seeking to monitor their patients and drive key decisions that can help improve patient care.
When you take into account the labor shortages in healthcare and the experience-
CEOCFO: Is it easier these days to get an audience to present what you are doing, because of the shortages, than it might have been some time back? How are you getting the attention you deserve?
Mr. Cooke: We had seen a lot of changes over the last few years and in some respect, I believe there is a greater understanding of the need for a platform such as Etiometry, which can help drive those decisions.
Etiometry has remote monitoring component to it, so you can be monitoring a patient from afar just like you are right at the bedside. There is huge value to that, especially with so many care teams feeling like they are stretched thin, while being short-
CEOCFO: Do the people you talk with at hospitals have any doubt of the validity of the data or the fact that these things can be done electronically? Are people still skeptical about AI?
Mr. Cooke: Any skepticism I may have seen in the early days, now that I have been with the company for three and-
There is also a growing body of published clinical evidence. Last year alone there were eight new clinical publications supporting the platform. When you start amassing the amount of supporting clinical data we have, I think that skepticism goes away.
CEOCFO: What is the competitive landscape? Are many companies trying to get into this arena?
Mr. Cooke: There are a few other niche solutions that are being used for data collection for research, meaning that some of the components of their platform and our platform are similar. However, they tend to be used retrospectively. They are collecting data for centers that are doing a lot of research, academic centers etc., that may be looking at that high-
The differentiating capability of our platform, and there is no other company that does what we do, is we are right by the bedside driving clinical decisions with FDA-
We want to be side-
CEOCFO: Would you tell us about the recent CE mark and Health Canada authorization for the IVCO2 Index™?
Mr. Cooke: We have had several new regulatory clearances, actually six in just the last couple of years. All four of our algorithms are authorized for pediatric use. Our inadequate delivery of oxygen index is cleared for all patients in Europe, Canada and the United States. Earlier this year, our IVCO2 Index was cleared for adults in Europe and Canada. This algorithm offers a way to understand the risk of hypercapnia, or inadequate ventilation of carbon dioxide.
We are looking at other markets as well. Regulatory clearances help pave the way for future growth for the company. Expanding the patient population to cover all ages is critical for us and you will see more of that from Etiometry moving forward as well as expanding geographically. It opens up new avenues of growth for us.
CEOCFO: Do hospitals and facilities operate essentially the same way in Canada and Europe as the United States, or are there differences you have been able to recognize that may cause you to slightly alter the way you might work with an organization?
Mr. Cooke: Each hospital in the U.S. tends to be different in terms of their clinical pathways and protocols – not to mention how they may differ a bit from geography to geography. Luckily, we built the Etiometry platform to be easily configurable to each institution’s protocols, and frankly it is a very quick process for us to customize and implement at each site.
The same thing goes for outside of the U.S. and some of the new markets that we are getting into. There are some subtle differences, but I would say in general, nothing significant. Thankfully, human physiology is the same regardless of where you go, and this is what drives a lot of the workflows we see.
CEOCFO: Are there cultural differences which you need to pay attention to as part of global expansion?
Mr. Cooke: When it comes to our platform, most of the cultural differences I see are on the business side rather than about the clinical care of patients. Health systems and insurance agencies are set up much differently in the different geographies. You may experience a tender process or a contract process in Europe, and healthcare is nationalized in Canada, so it’s our approach to partnering with systems outside the U.S. that is different.
CEOCFO: What would you like to be able to do that you have not figured out yet, either because the technology is not there yet, or the science does not yet know some of the problems that could be solved?
Mr. Cooke: In simple terms, our platform brings together important data to enable clinicians to view one source to make informed decisions, quickly. We continue to build on this one-
What if this could be automated? Enabling workflows to manage medical conditions such as sepsis, heart failure, and eventually moving into the homecare space, are key roadmap items for the company. We are on a path to help automate burdensome elements of care to help care teams throughout the world.
CEOCFO: Where does cost of your services come into the picture?
Mr. Cooke: In general, the cost of healthcare, especially in the U.S., is something that hospitals have to constantly be mindful of. Aside from discussing DRG (Diagnosis-
When we talk to hospitals, we discuss the economics a lot. We go into our return-
It has to be a solution that makes sense for them financially and can help them economically. First and foremost, it needs to drive improvements in patient care and for the teams caring for these patients. They have a tough job, and we want to make things easier for them.
CEOCFO: What if any challenges are you on the lookout for in the next year or so at Etiometry?
Mr. Cooke: One area I’m watching is the financial situation in the world, including the economic landscape, the recession and some of the issues that are going on in the banking industry right now.
The economy also has an impact on some hospitals and their financials; however, we can actually help in this regard. For example, we have data on how the Etiometry platform is reducing length of stay and readmissions. The other challenge we are tackling is not unique to Etiometry. It’s the complexity of getting into a new hospital or health system. There are a lot of stakeholders, so we aim to quickly engage those who are interested and get our platform utilized in more and more beds.
Finally, as we continue to experience high growth, there’s a persisting need to quickly expand our team. Our priority here is to maintain a great place to work and create positive experiences for our talent in order to get in front of any growing pains and continue to attract smart people.
CEOCFO: What if anything should people know about Etiometry that we did not discuss?
Mr. Cooke: We talked about a lot of things, but it’s interesting that a key contributor to advancing the Etiometry mission continues to be a track-
Etiometry | Shane Cooke | Clinical Data Analysis Tools | Clinical Data Systems | Intensive Care Unit Information Technology | The Etiometry Platform Now Offers Hospitals Customizable Clinical Pathway Automation to Drive Protocols, Workflows, Guidelines and Help with Staff Efficiency | CEO Interviews 2023 | Medical Companies | AI in healthcare, care protocols, CDSS, clinical care pathways, clinical data system, clinical quality improvement, clinical support systems in healthcare, critical care burnout, critical care data, critical care patient management, critical care research, decision support healthcare, decrease LOS, EHR decision support, EMR decision support, eICU, ERAS, enhanced recovery after, surgery protocols, experience complexity gap, extubation readiness, goal directed therapy, healthtech, hospital quality initiatives, ICU burnout, ICU data, ICU liberation, ICU patient management, ICU research, Machine learning in healthcare, medical decision support software, remote ICU, virtual ICU, Etiometry Inc. Press Release, Linkedin